DREQX
Price
$22.85
Change
-$0.03 (-0.13%)
Updated
Dec 3 closing price
Net Assets
1.74B
RGACX
Price
$86.23
Change
+$0.52 (+0.61%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

DREQX vs RGACX

Header iconDREQX vs RGACX Comparison
Open Charts DREQX vs RGACXBanner chart's image
BNY Mellon Research Growth Z
Price$22.85
Change-$0.03 (-0.13%)
VolumeN/A
Net Assets1.74B
American Funds Growth Fund of Amer R3
Price$86.23
Change+$0.52 (+0.61%)
VolumeN/A
Net Assets338.91B
DREQX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
DREQX vs. RGACX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DREQX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 339B vs. DREQX (1.74B). RGACX pays higher dividends than DREQX: RGACX (0.07) vs DREQX (0.00). DREQX was incepted earlier than RGACX: DREQX (54 years) vs RGACX (24 years). RGACX (0.94) is less costly to investors than DREQX (0.86). DREQX is a more actively managed with annual turnover of: 27.94 vs. RGACX (25.00). RGACX has a lower initial minimum investment than DREQX: RGACX (250) vs DREQX (1000). RGACX annual gain was more profitable for investors over the last year : 6.46 vs. DREQX (3.13). RGACX return over 5 years is better than : 29.83 vs. DREQX (5.61).
DREQXRGACXDREQX / RGACX
Total Expense Ratio0.800.9485%
Annual Report Gross Expense Ratio0.860.9491%
Fund Existence54 years24 years-
Gain YTD9.10818.55849%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.74B339B1%
Annual Yield % from dividends0.000.07-
Returns for 1 year3.136.4648%
Returns for 3 years65.6560.09109%
Returns for 5 years5.6129.8319%
Returns for 10 years50.5189.9056%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEPH5.430.20
+3.80%
Nephros
WTFCN26.34-0.03
-0.11%
Wintrust Financial Corp
HSIC71.65-1.46
-2.00%
Henry Schein
PTLO4.94-0.14
-2.76%
Portillo's
NRIX16.35-0.56
-3.31%
Nurix Therapeutics